返回新聞
創新AI Understanding 簡報

Insilico Medicine 的 Alex Zhavoronkov 押注中國和人工智慧可以實現製藥業的下一個突破

Insilico Medicine 的 Alex Zhavoronkov 相信中國和人工智慧可以實現製藥業的下一個突破。

4 min readRead the original reporting
Source-provided image accompanying Insilico Medicine's Alex Zhavoronkov bets China and AI can deliver the drug industry's next breakthrough
歸因報告來源記錄
出版商
fortune.com
來源連結
fortune.comhttps://fortune.com/2026/09/18/insilico-medicine-bets-china-and-ai-can-deliver-the-drug-industry-next-breakthrough/
來源類型
新聞媒體的報道-不是第一方文件。

我們無法獨立確認的內容: 此聲明歸因於指定的商店。我們沒有根據第一方文件對其進行驗證。 (fortune.com)

背景60 秒內了解這一點

從這裡開始

測試一下自己什麼是人工智慧?測驗

發生了什麼事

Insilico Medicine's Alex Zhavoronkov believes China and AI can deliver the drug industry's next breakthrough. The company is running a Phase 3 trial in China for its AI-discovered drug rentosertib, which is for idiopathic pulmonary fibrosis. Insilico used AI to identify the disease target and develop the molecule to treat it. The company has also launched LongevityBench, a test of large language models' grasp of aging biology.

Insilico Medicine 的 Alex Zhavoronkov 相信中國和人工智慧可以實現製藥業的下一個突破。

The company is running a Phase 3 trial in China for its AI-discovered drug rentosertib, which is for idiopathic pulmonary fibrosis.

Insilico used AI to identify the disease target and develop the molecule to treat it.

The company has also launched LongevityBench, a test of large language models' grasp of aging biology.

Insilico's strategy of using Chinese resources and talent to develop products for the Chinese market could be a key factor in its success.

來源詳情: fortune.com ↗

為什麼這很重要

Insilico Medicine's success in China and its use of AI to develop drugs could be a game-changer for the pharmaceutical industry. The company's AI-discovered drug rentosertib is in Phase 3 trials, and its LongevityBench test could help improve the understanding of aging biology. Insilico's strategy of using Chinese resources and talent to develop products for the Chinese market could also be a key factor in its success.

Insilico Medicine's success in China and its use of AI to develop drugs could be a game-changer for the pharmaceutical industry.

The company's AI-discovered drug rentosertib is in Phase 3 trials, and its LongevityBench test could help improve the understanding of aging biology.

Insilico's strategy of using Chinese resources and talent to develop products for the Chinese market could also be a key factor in its success.

The company's use of AI could help improve the understanding of aging biology and lead to the development of new treatments.

Insilico's success could lead to a shift in the way drugs are developed and marketed.

Interactive Mechanism

互動機制:它實際上是如何運作的

以互動方式探索這項發展背後的基礎技術。

Thinking Budget (Test-Time Tokens):1,024 tokens
Complex Accuracy79%Math & Code Logic
Latency3.2sTime to first full output
Inference Cost$0.0092Per query estimated
Reasoning StyleStep VerificationInternal chain depth
Active Thinking Trace:
1Deconstruct user problem into formal constraints
2Propose candidate hypotheses & step-by-step calculation
3Self-correction: Backtrack and refute subtle edge cases
4Exhaustive consistency check & final output synthesis
Core takeaway: Test-time compute fundamentally changes AI economics. Instead of only scaling during pre-training, giving reasoning models more tokens at inference time allows them to systematically solve PhD-level STEM problems.
互動式概念檢查+10 Points
What is AI? Quiz

A route planner searches possible journeys using explicit rules. What does this illustrate about AI?

接下來看什麼

Insilico Medicine's progress in China and its use of AI to develop drugs will be closely watched by the pharmaceutical industry. The company's success could lead to a shift in the way drugs are developed and marketed, and its use of AI could help improve the understanding of aging biology.

Insilico Medicine's progress in China and its use of AI to develop drugs will be closely watched by the pharmaceutical industry.

The company's success could lead to a shift in the way drugs are developed and marketed.

Insilico's use of AI could help improve the understanding of aging biology and lead to the development of new treatments.

The company's strategy of using Chinese resources and talent to develop products for the Chinese market could be a key factor in its success.

Insilico's success could help address the issue of longevity inequality.

相關指引和測驗

什麼是人工智慧?AI 倫理人工智慧代理人工智慧模型解釋AI 的未來測試你所知道的—嘗試免費的人工智慧測驗在我們的詞彙表中尋找人工智慧術語關注 AI 模型發布追蹤器
覺得有用嗎?